Tag
This research paper investigates how creatine uptake enhances antitumor immune responses, based on scientific findings in immunology and oncology.
The article discusses how AI could dramatically accelerate biomedical research, creating a bottleneck where current clinical trial and regulatory processes may delay patient access to new treatments, calling for urgent adaptation to the pace of AI-driven discoveries.
The Trump administration plans to give Russell Vought, head of the OMB, veto power over all NIH grants, a move that could politicize biomedical research funding. This follows previous attempts to control NIH grants, which faced legal and congressional pushback.
The article reports on AI BioDesign, a project using artificial intelligence and experiments to create molecules not found in nature, led by Nobel laureate David Baker, aiming to advance medicine and technology.
The paper introduces PASS, an agentic AI system that predicts publication venues for manuscripts by analyzing literature context, achieving high accuracy and outperforming baselines, and is released as a public platform for researchers.
Researchers have identified a genetic mutation named PIN in malaria parasites that reduces sensitivity to common antimalarial drugs, spreading rapidly in Uganda and threatening malaria control efforts.
Researchers at MIT and colleagues have developed a new mRNA adjuvant that boosts T-cell responses to vaccines, demonstrating promising results in mouse models for cancer and infectious diseases, which could lead to more effective treatments.
An MIT-developed medical database evolved into PhysioNet, a global biomedical data repository used by thousands of researchers worldwide, as detailed in a recent Nature Health paper.
An HIV vaccine developed by La Jolla Institute for Immunology and Scripps Research has shown unprecedented success in generating broadly neutralizing antibodies in primates, with human trials now underway.
Researchers are exploring agentic AI as co-scientists that can independently assist with ideation, hypothesis generation, and accelerating scientific exploration in biomedical research.
DeepMind's Co-Scientist AI tool bridges the expertise of two researchers from different biological fields to accelerate ALS research by generating testable hypotheses and identifying RNA-based mechanisms for potential therapies.
Researchers developed new antibiotics from scorpion venom and habanero peppers, demonstrating efficacy against resistant bacteria including tuberculosis strains, with ongoing work towards clinical trials.